These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 10602894

  • 1. Long-term follow-up of patients after related- and unrelated-donor bone marrow transplantation for chronic myelogenous leukemia.
    Reiter E, Greinix HT, Keil F, Brugger S, Rabitsch W, Schulenburg A, Mannhalter C, Schwarzinger I, Worel N, Volc-Platzer B, Fischer G, Dieckmann K, Hinterberger W, Schneider B, Haas OA, Geissler K, Kalhs P.
    Ann Hematol; 1999 Nov; 78(11):507-13. PubMed ID: 10602894
    [Abstract] [Full Text] [Related]

  • 2. Long term follow up after allogeneic stem cell transplantation for chronic myelogenous leukemia.
    Reiter E, Greinix HT, Brugger S, Keil F, Rabitsch W, Mannhalter C, Schwarzinger I, Höcker P, Fischer G, Dieckmann K, Hinterberger W, Linkesch W, Schneider B, Lechner K, Kalhs P.
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S86-8. PubMed ID: 9916646
    [Abstract] [Full Text] [Related]

  • 3. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK.
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [Abstract] [Full Text] [Related]

  • 4. Allogeneic bone marrow transplantation for chronic myeloid leukemia: a retrospective study of busulfan-cytoxan versus total body irradiation-cytoxan as preparative regimen in Koreans.
    Kim I, Park S, Kim BK, Chang HM, Bang SM, Byun JH, Kim DJ, Min WS, Kim HJ, Kim CC.
    Clin Transplant; 2001 Jun; 15(3):167-72. PubMed ID: 11389706
    [Abstract] [Full Text] [Related]

  • 5. Allogeneic bone marrow transplantation for chronic myeloid leukemia: a single center experience.
    Vela-Ojeda J, Tripp-Villanueva F, Sánchez-Cortés E, Ayala-Sánchez M, Rosas-Cabral A, Esparza MG, García-Chávez J, García-León LD, González-Llaven J.
    Arch Med Res; 2000 Jun; 31(2):206-9. PubMed ID: 10880729
    [Abstract] [Full Text] [Related]

  • 6. T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation.
    Drobyski WR, Hessner MJ, Klein JP, Kabler-Babbitt C, Vesole DH, Margolis DA, Keever-Taylor CA.
    Blood; 1999 Jul 15; 94(2):434-41. PubMed ID: 10397710
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Outcome of Chinese patients with chronic myeloid leukaemia (CML) underwent allogeneic bone-marrow transplantation (BMT).
    Lee CK, Lie AK, Liang R, Au WY, Chen FE, Chim CS, Kwong YL.
    Am J Hematol; 1999 Jun 15; 61(2):85-9. PubMed ID: 10367784
    [Abstract] [Full Text] [Related]

  • 9. Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia.
    Drobyski WR, Ash RC, Casper JT, McAuliffe T, Horowitz MM, Lawton C, Keever C, Baxter-Lowe LA, Camitta B, Garbrecht F.
    Blood; 1994 Apr 01; 83(7):1980-7. PubMed ID: 8142664
    [Abstract] [Full Text] [Related]

  • 10. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T, Van Lint MT, Gualandi F, Occhini D, Barbanti M, Sacchi N, Ficai G, Ghinatti C, Ferrara GB, Delfino L, Pozzi S, Morabito A, Zikos P, Vitale V, Corvo R, Frassoni F, Bacigalupo A.
    Bone Marrow Transplant; 1997 Dec 01; 20(12):1057-62. PubMed ID: 9466278
    [Abstract] [Full Text] [Related]

  • 11. Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation.
    Weisdorf DJ, Anasetti C, Antin JH, Kernan NA, Kollman C, Snyder D, Petersdorf E, Nelson G, McGlave P.
    Blood; 2002 Mar 15; 99(6):1971-7. PubMed ID: 11877268
    [Abstract] [Full Text] [Related]

  • 12. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY.
    Ai Zheng; 2004 Apr 15; 23(4):426-9. PubMed ID: 15087032
    [Abstract] [Full Text] [Related]

  • 13. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G, Roy DC, Gonin R, Alyea EP, Bélanger R, Gyger M, Perreault C, Bonny Y, Lerra I, Murray C.
    J Clin Oncol; 1995 Jul 15; 13(7):1704-13. PubMed ID: 7602361
    [Abstract] [Full Text] [Related]

  • 14. Long-term survival in advanced chronic myelogenous leukemia following bone marrow transplantation from haploidentical related donors.
    Bishop MR, Henslee-Downey PJ, Anderson JR, Romond EH, Marciniak E, Yankey R, Reeves M, Thompson JS.
    Bone Marrow Transplant; 1996 Oct 15; 18(4):747-53. PubMed ID: 8899190
    [Abstract] [Full Text] [Related]

  • 15. Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children.
    Gamis AS, Haake R, McGlave P, Ramsay NK.
    J Clin Oncol; 1993 May 15; 11(5):834-8. PubMed ID: 8487047
    [Abstract] [Full Text] [Related]

  • 16. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F, Copelan E, Crilley P, Bolwell B, Avalos B, Klein J, Territo M, Gajewski J.
    Bone Marrow Transplant; 1996 May 15; 17(5):685-9. PubMed ID: 8733682
    [Abstract] [Full Text] [Related]

  • 17. Determinants of survival after human leucocyte antigen-matched unrelated donor bone marrow transplantation in adults.
    Barker JN, Davies SM, DeFor TE, Burns LJ, McGlave PB, Miller JS, Weisdorf DJ.
    Br J Haematol; 2002 Jul 15; 118(1):101-7. PubMed ID: 12100132
    [Abstract] [Full Text] [Related]

  • 18. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr 15; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 19. Case report of spontaneous remission of cytogenetic relapse of chronic myelogenous leukemia suggestive of progression to blast crisis after allogeneic bone marrow transplantation.
    Agaliotis DP, Papenhausen PR, Moscinski LC, Elfenbein GJ.
    Ann Hematol; 1995 Jan 15; 70(1):37-41. PubMed ID: 7827205
    [Abstract] [Full Text] [Related]

  • 20. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
    Huss R, Deeg HJ, Gooley T, Bryant E, Leisenring W, Clift R, Buckner CD, Martin P, Storb R, Appelbaum FR.
    Bone Marrow Transplant; 1996 Oct 15; 18(4):767-76. PubMed ID: 8899193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.